Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Benefit of Antithymocyte Induction Therapy on Hepatic Fibrosis in de Novo Hepatitis C Virus Liver Transplant Patients.

NCT00538265 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT00538265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00538265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Benefit of Antithymocyte Induction Therapy on Hepatic Fibrosis in de Novo Hepatitis C Virus Liver Transplant Patients.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
January 31, 2011
Enrollment
100 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation